Loncar China Biopharma ETF (%)
(CHNA)| Years | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | ||||
| 2024 | 0 | 0 | ||
| 2023 | -5.11 | -9.15 | -11.87 | -4.61 |
| 2022 | -23.5 | -2.34 | -28.16 | 30.71 |
| 2021 | 13.27 | 43.94 | -29.75 | -19.88 |
| 2020 | -8.39 | 35.32 | -0.54 | -4.62 |
| Years | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | ||||
| 2024 | 0 | 0 | ||
| 2023 | -5.11 | -9.15 | -11.87 | -4.61 |
| 2022 | -23.5 | -2.34 | -28.16 | 30.71 |
| 2021 | 13.27 | 43.94 | -29.75 | -19.88 |
| 2020 | -8.39 | 35.32 | -0.54 | -4.62 |